ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Evaluation of Serum sCD30 as a Predictor in Kidney Transplant Recipients

X.-Z. Wang, W.-J. Xue, X.-H. Tian, J. Zheng, P.-X. Tian, X.-M. Ding.

Kidney Transplantation, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Meeting: 2015 American Transplant Congress

Abstract number: D155

Keywords: Infection, Kidney/liver transplantation, Outcome, Rejection

Session Information

Session Name: Poster Session D: Kidney: Acute Rejection

Session Type: Poster Session

Date: Tuesday, May 5, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Objective To explore the significance of serum CD30 in predicting acute rejection and pneumonia in kidney transplant recipients. Methods A total of 106 kidney transplant recipients were recruited in this prospective six months follow-up study from December 2011 to October 2013. According to the clinical outcome, the subjects were devided into stable renal function group (52 cases), acute rejection group (34 cases) and pulmonary infection group (20 cases). Twenty healthy subjects were choosed as controls. Serum sCD30 levels were detected by ELISA. The whole peripheral blood samples were collected from all recipients before transplantation, at days 7, 14, 21 and 28 post-transplantation, and at months 2, 3, 4, 5 and 6 post-transplantation. Additional blood samples were collected for on the days that acute rejection or infection occurred and reversed. Results When acute rejection occurred, serum sCD30 levels in AR group was 50.38 ± 12.10 ng/mL, which was significantly higher than stable group (20.03± 6.68 ng/mL, P<0.05) and healthy control group (13.57±5.56 ng/mL, P<0.05). After the anti-rejection therapy, serum sCD30 levels decreased to 15.31 ± 6.37 ng/mL, which was lower than that before the therapy started (50.38 ± 12.10 ng/mL, P<0.05). Elevated preoperative serum sCD30 levels suggested a higher risk of acute rejection in kidney transplant recipients, with Cutoff values of 24.96 ng/mL, and the sensitivity and specificity were 91.30% and 84.21% respectively. Whereas, preoperative sCD30 levels in pulmonary infection group were lower than stable group (21.34±8.65 ng/mL vs 26.51 ± 13.70 ng/mL, P<0.05), and a significant correlation was observed between high levels of sCD30 and lower incidence of infection, with Cutoff values of 18.19 ng/mL, and the sensitivity and specificity were 87.10% and 71.43% respectively. Conclusion Our data suggest that dynamic monitoring of sCD30 levels can predict and assess the risks of rejection and infection episodes in kidney transplant recipients.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Wang X-Z, Xue W-J, Tian X-H, Zheng J, Tian P-X, Ding X-M. Evaluation of Serum sCD30 as a Predictor in Kidney Transplant Recipients [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/evaluation-of-serum-scd30-as-a-predictor-in-kidney-transplant-recipients/. Accessed May 9, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences